All ten H2020 projects involve semiconductor component manufacturing, from More-than-Moore pilot lines (ADMONT) to sensor substrates (PRYSTINE) and medical device fabrication (InForMed, POSITION-II, Moore4Medical).
OKMETIC OY
Finnish specialty silicon wafer manufacturer supplying substrates for automotive sensors, medical implants, and advanced semiconductor components across European pilot lines.
Their core work
Okmetic is a Finnish specialty silicon wafer manufacturer that supplies advanced substrates for semiconductor components, MEMS sensors, and microfabricated medical devices. Within H2020 consortia, they contribute their wafer fabrication and materials expertise to pilot lines and product development across automotive electronics, medical implants, and smart sensing systems. Their role is typically as a materials and substrate supplier enabling downstream component manufacturing in large-scale European electronics initiatives.
What they specialise in
Four projects focus on medical applications: InForMed (micro-fabricated medical devices), ASTONISH (optical imaging for health), POSITION-II (smart catheters and implants), and Moore4Medical (microfabricated medical devices).
Four projects target automotive electronics: 3Ccar (electrified cars), AutoDrive (fail-aware components), PRYSTINE (intelligence in automobiles), and NewControl (highly automated vehicles).
iRel40 focuses on Quality 4.0, physics of failure, and design for reliability; AutoDrive addresses fail-aware and fail-safe electronic architectures.
ASTONISH (smart optical imaging), PRYSTINE (sensors for autonomous driving), and NewControl (LIDAR/RADAR fusion) all require specialized sensor-grade silicon substrates.
How they've shifted over time
Okmetic's early H2020 involvement (2015-2018) centered on broad semiconductor pilot lines and medical device microfabrication, with projects like ADMONT (More-than-Moore technologies) and InForMed establishing their role as a substrate supplier. From 2017 onward, their portfolio shifted significantly toward two verticals: automotive-grade semiconductors for autonomous driving (PRYSTINE, NewControl) and advanced medical implantables (POSITION-II, Moore4Medical), with a new emphasis on reliability and AI-driven quality control (iRel40). This shows a clear move from general semiconductor supply toward higher-value, safety-critical application domains.
Okmetic is positioning itself as a supplier of safety-critical, high-reliability silicon substrates for automotive autonomy and implantable medical devices — two domains where material quality requirements are exceptionally stringent.
How they like to work
Okmetic operates exclusively as a participant, never coordinating projects, which is consistent with their role as a specialized materials supplier within large European electronics ecosystems. With 325 unique consortium partners across 26 countries and heavy involvement in ECSEL Joint Undertaking projects, they work comfortably in very large consortia (often 30-60+ partners). This makes them a reliable, low-friction partner that integrates into existing supply chain structures rather than driving project direction.
Okmetic has built an exceptionally broad network of 325 unique partners across 26 countries, driven by participation in large ECSEL Joint Undertaking consortia that bring together entire European semiconductor value chains. Their network spans major European electronics hubs including Germany, France, Netherlands, Austria, and the Nordic countries.
What sets them apart
Okmetic occupies a rare position as one of Europe's few independent specialty silicon wafer manufacturers, making them a strategic upstream supplier for any consortium that needs custom substrates for MEMS, sensors, or advanced semiconductor components. Unlike generic wafer suppliers, their H2020 track record demonstrates validated experience across both medical-grade and automotive-grade substrate requirements — two domains with the most demanding quality certifications. For consortium builders, Okmetic fills the critical "wafer supply" slot that most European electronics projects need but few companies can credibly provide.
Highlights from their portfolio
- POSITION-IILargest single funding (EUR 239,000) — a pilot line for next-generation smart catheters and implants, representing Okmetic's deepest commitment to medical device substrates.
- iRel40Signals a strategic move into reliability engineering and Quality 4.0, applying AI and physics-of-failure methods to semiconductor reliability — a forward-looking capability for safety-critical markets.
- NewControlSecond-largest funding (EUR 221,562) focused on fail-operational systems for highly automated vehicles, positioning Okmetic in the autonomous driving supply chain with LIDAR and RADAR sensor substrates.